World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
25597
World Ranking
17938
National Ranking
1634

John Feehally publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John Feehally sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 363 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John Feehally D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John Feehally sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John Feehally is affiliated with the University of Leicester in the United Kingdom. Their research primarily centers on the field of Medicine, with a particular focus on Nephrology, supported by numerous publications. They have contributed to 54 publications in Medicine, including 33 in Nephrology, alongside works in Immunology, Rheumatology, Hematology, and Pathology and Forensic Medicine.

The main topics addressed in their work encompass Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Systemic Lupus Erythematosus Research, Platelet Disorders and Treatments, Complement system in diseases, and Renal Transplantation Outcomes and Treatments.

Frequent publication venues for John Feehally include:

  • Kidney International (8 publications)
  • Kidney International Reports (5 publications)
  • Kidney International Supplements (2 publications)
  • UNC Libraries (2 publications)
  • Journal of the American Society of Nephrology (2 publications)

John Feehally has collaborated frequently with co-authors such as:

  • Vivekanand Jha (10 joint publications)
  • David W. Johnson (9 joint publications)
  • Jonathan Barratt (8 joint publications)
  • Vlado Perkovic (7 joint publications)
  • Adeera Levin (6 joint publications)

Some recent papers authored or co-authored by John Feehally include:

  • Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy, 2022, JAMA
  • Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes, 2020, Kidney International Supplements
  • Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy, 2020, Kidney International
  • Challenges of access to kidney care for children in low-resource settings, 2020, Nature Reviews Nephrology
  • Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study, 2021, PLoS Medicine

Best Publications

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology

    Ravindra L Mehta;Jorge Cerdá;Emmanuel A Burdmann;Marcello Tonelli

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    Hernán Trimarchi;Jonathan Barratt;Daniel C. Cattran;H. Terence Cook

  • Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

    Krzysztof Kiryluk;Yifu Li;Francesco Scolari;Simone Sanna-Cherchi

  • Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy

    H.C. Stanescu;M. Arcos-Burgos;A. Medlar;D. Bockenhauer

  • Comprehensive Clinical Nephrology

    Richard J. Johnson;John Feehally

  • Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

    Rosanna Coppo;Stéphan Troyanov;Shubha Bellur;Daniel Cattran

  • Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial

    Jicheng Lv;Jicheng Lv;Hong Zhang;Muh Geot Wong;Meg J. Jardine

  • Assessment of Global Kidney Health Care Status

    Aminu K. Bello;Adeera Levin;Marcello Tonelli;Ikechi G. Okpechi

  • Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study

    Ravindra L Mehta;Emmanuel A Burdmann;Jorge Cerdá;John Feehally

  • Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

    Bengt C Fellström;Jonathan Barratt;Heather Cook;Rosanna Coppo

  • Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

    Sean J Barbour;Rosanna Coppo;Hong Zhang;Zhi-Hong Liu

  • Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.

    A. C. Allen;S. J. Harper;J. Feehally

  • The MEST score provides earlier risk prediction in lgA nephropathy

    Sean J. Barbour;Sean J. Barbour;Gabriela Espino-Hernandez;Heather N. Reich;Rosanna Coppo

  • HLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis

    John Feehally;Martin Farrall;Anne Boland;Daniel P. Gale

  • A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy

    Mark Haas;Jacobien C. Verhave;Zhi Hong Liu;Charles E. Alpers

  • Physical Exercise in Patients with Severe Kidney Disease

    G.C. Kosmadakis;A. Bevington;A.C. Smith;E.L. Clapp

  • Treatment of IgA nephropathy

    J. Barratt;J. Feehally

Frequent Co-Authors

Vivekanand Jha
Vivekanand Jha George Institute for Global Health
Paul Roderick
Paul Roderick University of Southampton
David Harris
David Harris University of Sydney
Adeera Levin
Adeera Levin University of British Columbia
Daniel C. Cattran
Daniel C. Cattran University Health Network
Marcello Tonelli
Marcello Tonelli University of Calgary
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Yoav Ben-Shlomo
Yoav Ben-Shlomo University of Bristol
Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh University of California, Irvine
Zhihong Liu
Zhihong Liu Nanjing University

External Links

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine or healthcare in the USA offers a diverse range of online degree pathways, especially for those seeking flexibility or accelerated learning. Many professionals are choosing to upgrade their credentials through rn to bsn programs without clinicals, which help registered nurses obtain a Bachelor of Science in Nursing without the need for on-campus clinicals—a practical choice for working nurses.

For nurses aiming to fast-track their career to leadership or advanced practice roles, enrolling in the fastest dnp program can be an excellent option. These Doctor of Nursing Practice programs are designed to be completed in less time, making advancement more accessible. Affordability is another key consideration—students can benefit from many affordable dnp programs that combine quality education with financial value.

If you’re looking to enter the healthcare field sooner, consider beginning with an accelerated lpn program online. These fast-track Licensed Practical Nurse pathways can help you start working and gaining valuable experience right away, laying the foundation for future advancement in medicine and nursing.

Best Scientists Citing John Feehally

Trending Scientists

Recently Published Articles